Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-04-23

FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for Zenatane (isotretinoin) submitted by BluePoint Laboratories. The document indicates a supplemental approval for this…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENATANE (Isotretinoin)

Snippet

SUPPL AP for ZENATANE (ISOTRETINOIN)